EP12.01. Successful Salvage Therapy Using High Dose Aumolertinib in T790M-negative EGFR-mutant NSCLC With Brain and Leptomeningeal Metastases - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yi-Bin Li
Meta Tag
Speaker Yi-Bin Li
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
salvage therapy
metastatic non-small cell lung cancer
high dose Aumolertinib
T790M-negative EGFR mutation
brain metastases
leptomeningeal metastases
first and third-generation TKI treatments
progression-free survival
Powered By